CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Current assets
Cash	$ 2,578	$ 5,965
Prepaid drug product for testing	1,332	1,117
Other current assets	604	353
Total current assets	4,514	7,435
Fixed assets
Furniture, fixtures & equipment	1,001	984
Less accumulated depreciation	(462)	(330)
Property, Plant and Equipment, Net	539	654
Other assets
Technology licenses	2,500	2,500
Less accumulated amortization	(1,811)	(1,731)
Intangible Assets, Net (Excluding Goodwill), Total	689	769
Total Assets	5,742	8,858
Current liabilities
Accounts payable	137	52
Accrued expenses	868	739
Total current liabilities	1,005	791
Total Liabilities	1,005	791
Shareholders' equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value; 200,000 shares authorized; 11,341 and 11,339 shares issued and outstanding, respectively	11	11
Additional paid in capital	47,476	47,213
Accumulated deficit	(42,750)	(39,157)
Total shareholders' equity	4,737	8,067
Total Liabilities & Shareholders' Equity	$ 5,742	$ 8,858